(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 256080 - Group A Strep and Flu Analyzer Combo Kit with Veritor Plus Analyzer, CLIA-Waived Testing System

BD  # 256080 - Group A Strep and Flu Analyzer Combo Kit with Veritor Plus Analyzer, CLIA-Waived Testing System
Part Number BD 256080
SKU Number CIA8041320
Sell Unit EACH
Ships Within Special Order
List Price $810.95
Enter a valid quantity
Product Description

BD 256080 - Group A Strep and Flu Analyzer Combo Kit with Veritor Plus Analyzer, CLIA-Waived Testing System

The BD 256080 Veritor Group A Strep + Flu Kit + Analyzer Combo is a comprehensive point-of-care diagnostic testing solution that combines the BD Veritor Plus Analyzer with Group A Streptococcus and Influenza A+B testing capabilities. This integrated package is designed to help healthcare providers rapidly evaluate patients presenting with respiratory illness symptoms by providing access to multiple commonly requested diagnostic tests in a single platform.

The combo package includes one BD Veritor Plus Analyzer, two BD Veritor Group A Strep test kits, and one BD Veritor Flu A+B CLIA-waived test kit. The analyzer provides automated digital interpretation of test results, helping reduce subjective visual reading and supporting consistent diagnostic workflows.

This solution is designed for professional healthcare environments seeking efficient point-of-care testing for patients with symptoms that may be associated with influenza or Group A Streptococcal infections.

Manufacturer256080
ApplicationRespiratory Test Kit
Purchase Program TypePromotion
Test Kit TypeRapid

Key Benefits

The BD 256080 Combo Kit provides a convenient diagnostic platform capable of supporting testing for both influenza and Group A Streptococcus using a single analyzer. This helps streamline workflow and reduces the need for multiple testing platforms.

The automated digital interpretation offered by the Veritor Plus Analyzer helps improve consistency by minimizing subjective visual result assessment. This can support more standardized testing practices across multiple users and locations.

The inclusion of both influenza and strep testing capabilities allows healthcare providers to evaluate patients with overlapping respiratory symptoms more efficiently, supporting timely clinical decision-making and patient management.

The CLIA-waived influenza testing component can help eligible facilities implement rapid testing with simplified regulatory requirements compared with more complex laboratory methods.

Compatibility and Applications

The BD 256080 Combo Kit is designed for use with the included BD Veritor Plus Analyzer and compatible BD Veritor diagnostic assays. The analyzer serves as the central platform for processing and interpreting supported BD Veritor test devices.

Typical applications include evaluation of sore throat symptoms, influenza-like illness assessment, respiratory infection screening, outpatient diagnostic testing, urgent care evaluations, and point-of-care infectious disease testing.

This solution is commonly used in physician offices, urgent care centers, outpatient clinics, retail health clinics, pediatric practices, student health centers, occupational health facilities, and community healthcare settings.

Usage Guidelines

The BD 256080 Combo Kit should be used only by trained healthcare personnel following manufacturer instructions, applicable CLIA requirements, and facility protocols. Prior to testing, verify analyzer functionality, test kit integrity, expiration dates, and quality control requirements.

Collect patient specimens according to the instructions provided with the appropriate BD Veritor test kit. Process the specimen following the designated procedure and insert the test device into the Veritor Plus Analyzer for automated result interpretation.

Follow all recommended quality control procedures, analyzer maintenance requirements, and documentation protocols. Do not use expired or damaged testing materials.

Certifications and Safety Standards

The BD Veritor testing platform is manufactured under established quality management systems designed to meet applicable diagnostic testing and medical device standards. The included influenza test kit is CLIA-waived, supporting use in eligible healthcare environments that meet applicable regulatory requirements.

Healthcare facilities should review current product labeling, quality control requirements, regulatory documentation, and testing instructions prior to implementation. Compliance with federal, state, and local testing regulations should be maintained at all times.

Comparison with Competitor Products

Compared with visually interpreted rapid diagnostic tests, the BD Veritor Plus Analyzer provides automated digital interpretation, helping reduce variability and improve consistency in result reporting.

Compared with separate testing platforms for influenza and Group A Streptococcus, the BD 256080 Combo Kit offers a consolidated solution that supports multiple diagnostic applications using a single analyzer.

Compared with laboratory-based testing methods that may require longer turnaround times, the Veritor platform supports rapid point-of-care testing that can help accelerate patient evaluation and treatment decisions.

Typical User Profile and Application Scenarios

The BD 256080 Combo Kit is commonly used by physicians, nurse practitioners, physician assistants, nurses, medical assistants, laboratory personnel, and other healthcare professionals involved in point-of-care diagnostic testing.

Typical applications include evaluation of sore throat symptoms, influenza screening, pediatric respiratory illness assessment, urgent care patient evaluations, outpatient infectious disease testing, and seasonal respiratory illness management.

Best Practices for Use and Maintenance

Store the analyzer and test kits according to manufacturer specifications. Maintain appropriate environmental conditions and inventory controls to ensure testing materials remain within approved storage requirements.

Perform routine quality control testing, analyzer maintenance, and performance verification according to manufacturer recommendations. Ensure all personnel receive appropriate training before operating the system.

Maintain complete documentation of testing activities, quality control procedures, analyzer maintenance, and patient results in accordance with facility policies and regulatory requirements.

Regulatory and Safety Information

The BD 256080 Veritor Group A Strep + Flu Analyzer Combo is intended for professional healthcare use only. Testing should be performed by trained personnel following manufacturer instructions, infection control protocols, applicable CLIA requirements, and healthcare regulations.

All patient specimens should be treated as potentially infectious. Appropriate personal protective equipment should be used when handling specimens and testing materials. Facilities should maintain compliance with applicable federal, state, and local diagnostic testing regulations.

This product is designated as non-cancellable and non-returnable. Facilities should verify compatibility, testing requirements, and purchasing needs prior to placing an order.

How to Order

Select the BD 256080 Veritor Group A Strep Plus Flu Kit Analyzer Combo Including Two Group A Strep Kits, One Flu CLIA-Waived Kit, and One Veritor Plus Analyzer and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, implementation assistance, or further product information, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page.

Related Products